GlassScriptPhysician profile
Steven W Sukin
NPI 1154309516
$15,294.83
in general payments reported to CMS, 2019-2025
41 companies · $1,819 in 2025
The $1,819 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,966 · 2020: $274 · 2021: $367 · 2022: $1,833 · 2023: $2,153 · 2024: $5,883 · 2025: $1,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,399 · Travel and Lodging: $4,439 · Education: $16.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,399.24 |
| Travel and Lodging | $4,438.80 |
| Education | $16.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $4,874.48 | 2022-2025 | Tulsa-Pro |
| Boston Scientific Corporation | $2,426.99 | 2019-2025 | Ams 700, Tactra, Spaceoar Vue System - 10ml |
| Neotract INC. | $1,903.82 | 2019 | |
| Coloplast Corp | $998.73 | 2019-2023 | Altis |
| Procept Biorobotics Corporation | $822.89 | 2020-2025 | Aquabeam Robotic System, Aquabeam System |
| Teleflex LLC | $680.26 | 2021-2025 | Urolift |
| Abbvie INC. | $474.96 | 2022-2025 | Botox |
| Intuitive Surgical, INC. | $380.28 | 2019-2024 | Da Vinci Surgical System |
| Laborie Medical Technologies Corp. | $273.77 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Bioprotect Medical, INC. | $229.36 | 2025 | Bioprotect Balloon Implant System |
| Myriad Genetic Laboratories, INC. | $223.43 | 2023-2024 | Prolaris |
| Accord Healthcare, INC. | $221.40 | 2023-2024 | |
| Axonics, INC. | $197.00 | 2022-2024 | Axonics |
| Olympus America INC. | $187.09 | 2022-2024 | Itind System |
| Urogen Pharma, INC. | $184.53 | 2022-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $152.89 | 2022-2023 | |
| Agiliti Surgical, INC. | $126.70 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Janssen Biotech, INC. | $120.21 | 2019 | |
| Astellas Pharma US INC | $108.52 | 2019-2025 | Xtandi |
| Ethicon INC. | $102.68 | 2020 | |
| Pfizer INC. | $58.52 | 2019 | |
| Allergan, INC. | $53.73 | 2019-2020 | |
| Antares Pharma, INC. | $49.31 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Medtronic, INC. | $47.28 | 2023-2024 | Interstim |
| Tolmar Pharmaceuticals, INC. | $44.43 | 2022 | |
| Ambu INC. | $44.38 | 2021 | |
| Myovant Sciences INC. | $39.14 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $37.38 | 2020-2021 | |
| Argon Medical Devices, INC. | $31.68 | 2024 | Clot Management |
| Tolmar, INC. | $23.09 | 2025 | Jatenzo, Eligard |
| Bluewind Medical | $22.65 | 2025 | Revi |
| Kowa Pharmaceuticals America, INC. | $21.53 | 2023 | Seglentis |
| Blue Earth Diagnostics | $19.86 | 2019 | |
| Biotissue Holdings INC. | $18.93 | 2024 | |
| Telix Pharmaceuticals | $18.63 | 2023 | Illuccix |
| Ethicon US, LLC | $17.31 | 2024 | Vistaseal, Stratafix |
| Uc-Care (USA), INC | $16.56 | 2025 | Navigo Workstation |
| 180 Medical, INC. | $15.04 | 2024 | |
| Mission Pharmacal Company | $12.98 | 2019 | |
| Urovant Sciences INC | $12.41 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$0.05 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sukin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.